ACLX 67.23 (+10.76%)
US03940C1009BiotechnologyBiotechnology

Arcellx (ACLX) Stock Highlights

67.23 | +10.76%
2025-04-03 02:51:04
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.

Statistics

Range Today
59.45 67.34
Volume Today 908.6K
Range 1 Year
47.88 107.37
Volume 1 Year 135.38M
Range 3 Year
6.03 107.37
Volume 3 Year 383.51M
Range 10 Year
6.03 107.37
Volume 10 Year 391.45M

Highlights

Market Capitalization 3.73B (mid)
Floating Shares 32.6M
Current Price 67.23
Price To Earnings -34.27
Price To Revenue 29.65
Price To Book 8.11
Earnings Per Share -2
Payout Ratio 0%

Performance

Latest +10.76%
1 Month +3.88%
3 Months -12.59%
6 Months -16.58%
1 Year +2.99%
3 Years +351.51%
5 Years +253.84%
10 Years +253.84%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.